SERENOVA

Serenova envisions a world where customer experiences are so fluid and effortless that they're simply taken for granted. We're building that world with software that connects data, people, and brands for brighter interactions, insights, and outcomes.
SERENOVA
Industry:
Information Technology Software
Founded:
2000-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.serenova.com
Total Employee:
251+
Status:
Active
Contact:
(800) 411-4700
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Amazon Route 53 Pound Sterling Ruby On Rails Token Amazon S3 CDN
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-11-19 | ProScheduler | ProScheduler acquired by Serenova | N/A |
2017-10-23 | Telstrat | Telstrat acquired by Serenova | N/A |
Newest Events participated

Official Site Inspections
http://www.serenova.com
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Serenova"
Sernova Provides Organizational Update | sernova.com
Apr 25, 2024 Sernova partnered with Evotec to develop an implantable off-the-shelf iPSC (induced pluripotent stem cells) based islet replacement therapy. This partnership provides โฆSee details»
Innovating Regenerative Medicine | About Sernova
Our passion for helping people with chronic diseases is deeply rooted in the experiences of Jonathan Rigby, Chief Executive Officer of Sernova and a patient with type 1 diabetes (T1D). Our intimate understanding of the challenges โฆSee details»
Sernova - Crunchbase Company Profile & Funding
Sernova Corp., a health sciences company, focuses on the development and commercialization of medical technologies in the United States and Canada. โฆSee details»
A Regenerative Solution for Chronic Disease | Sernova
Toward a total regenerative solution. In addition to our comprehensive therapeutic solution built to address T1D, weโre developing comprehensive therapies for a range of indications in which patients are deficient in necessary hormones, โฆSee details»
Sernova Announces Marketed Public Offering of Units - Newswire
Jun 6, 2024 Sernova Corp. is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, โฆSee details»
Sernova Biotherapeutics Company Description - Stock Analysis
Apr 17, 2025 Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary โฆSee details»
Sernova Company Profile - Office Locations, Competitors ... - Craft
Aug 2, 2022 Sernova is a regenerative medicine technology company developing products for the treatment of chronic diseases such as diabetes and hemophilia. It uses therapeutic cells โฆSee details»
Sernova Corp. Announces Appointment of New Chief Executive
Aug 12, 2024 Sernova Corp. is a clinical-stage biotechnology company that is developing therapeutic cell technologies that are implanted in patients inside its Cell Pouchโข System for โฆSee details»
Serenova - Crunchbase Company Profile & Funding
Serenova may be growing as indicated by several key developments. The company's leadership was noted for creating a strong foundation that led to a merger with Lifesize, which could suggest an expansion of operations and โฆSee details»
Sernova - Overview, News & Similar companies | ZoomInfo.com
View Sernova (www.sernova.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โฆSee details»
Sernova 2025 Company Profile: Stock Performance & Earnings
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid โฆSee details»
Sernova Biotherapeutics Inc (SVA.TO)
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a โฆSee details»
Sernova Corporation Announces the Appointment of Cynthia โฆ
Sep 5, 2023 Sernovaโs management will host investor calls, firstly to introduce Ms. Pussinen, and later, in approximately 30 days, to provide an overview of Sernova as well as a question โฆSee details»
Sernova Announces Management Developments - TheNewswire
Sernova Corp. is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and โฆSee details»
Sernova Corp. Announces C$10 Million Bought Deal Offering of
LONDON, ON, Feb. 3, 2021 /CNW/ - Sernova Corp. ("Sernova" or the "Company") (TSXV: SVA) (OTCQB: SEOVF) (FSE: PSH), a leading clinical-stage regenerative medicine therapeutics โฆSee details»
Sernova - Products, Competitors, Financials, Employees, โฆ
Sernova is a clinical-stage regenerative medicine company focused on developing therapeutic technologies for chronic diseases such as insulin-dependent diabetes, hemophilia A, and thyroid disease. The company's flagship product, the Cell Pouch Systemโข, is an implantable medical device that creates a vascularized tissue environment for the ...See details»
Lifesize and Serenova Announce United Corporate Brand and New โฆ
Jun 18, 2020 AUSTIN, Texas--(BUSINESS WIRE)--Lifesize ®, a global innovator of immersive enterprise communication solutions, and Serenova, a leading contact center-as-a-service (CCaaS) provider, today ...See details»
Serenova - LinkedIn
Serenova | 11,466 followers on LinkedIn. As part of Lifesize, we are improving customer experiences in the contact center from anywhere and from any device. | Lifesize delivers โฆSee details»
Serenova 2025 Company Profile: Valuation, Investors ... - PitchBook
Information on acquisition, funding, investors, and executives for Serenova. Use the PitchBook Platform to explore the full profile.See details»
Investor Relations - Sernova
Apr 17, 2025 Sernova is a regenerative medicine company developing therapeutic technologies with multibillion-dollar market potential for each of its clinical indications. Press Releases. April 17, 2025. Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans.See details»